Automated CPR devices are mechanical chest compression devices that perform cardiopulmonary resuscitation (CPR) through automated and consistent chest compressions. These devices function through an attached mechanical arm that provides compressions to the chest during a cardiac arrest or emergency situation. They are designed to perform uninterrupted, consistent chest compressions during CPR to maximize blood flow to vital organs until spontaneous circulation returns or advanced life support takes over. Automated CPR devices help free up medical providers and minimize fatigue to providers when performing manual CPR for extended periods of time. Some key product types of automated CPR devices include load-distributing bands, compression pads, straps, vests, mats & boards. These devices are commonly used in hospital settings such as emergency rooms, intensive care units or ambulances to provide high quality CPR. Growing adoption of automated CPR devices in hospitals and ambulatory surgical centers driven by benefits of consistent, high quality chest compressions during CPR is expected to flourish the global automated CPR devices market.
The global Automated CPR Devices Market is estimated to be valued at US$ 127.06 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
One of the key drivers for the growth of the automated CPR devices market is the growing adoption of automated CPR devices in hospitals and ambulatory surgical centers. Automated CPR devices provide advantages of consistent, uninterrupted chest compressions compared to manual CPR. This leads to improved circulation during cardiac arrest and maximizes the likelihood of return of spontaneous circulation. Automated devices also minimize fatigue for medical providers performing CPR for extended periods and helps free up providers to focus on other emergency procedures. Growing recognition of benefits of automated CPR devices in hospital settings is expected to drive the demand.
The growing instances of cardiac arrest globally also contributes to the growing need for automated CPR devices market. According to the American Heart Association, over 350,000 out of hospital cardiac arrests occur in the US each year. Early use of CPR including after the arrival of emergency medical services can double or triple a cardiac arrest victim’s chance of survival. Availability of automated CPR devices can help improve survival rates by providing ongoing high quality chest compressions until advanced life support is available. This fuels the growth of automated CPR devices market.
Segment Analysis
The global automated CPR devices market can be segmented based on product type, end user, and region. Based on product type, the market is dominated by mechanical piston CPR devices sub-segment. These devices offer consistent, full-body compression which mimics manual chest compressions more accurately than other CPR devices. This helps provide uniform blood flow to the vital organs during resuscitation, increasing survival rates.
PEST Analysis
Political: Governments across countries are introducing policies and initiatives to raise awareness about importance of early resuscitation during cardiac arrest. This is increasing adoption of automated CPR devices in pre-hospital settings.
Economic: Rising geriatric population, growing prevalence of cardiovascular diseases, and improved reimbursement policies for life-saving devices are fueling the market growth.
Social: Increasing training programs on CPR and first-aid are positively influencing the demand for automated devices which provide consistent, high-quality chest compressions during cardiac events.
Technological: Advancements in material science, robotics, and electromechanical components are helping manufacturers develop enhanced devices with features like adjustable compression depth, audio-visual feedback, and compression monitoring.
Key Takeaways
The global automated CPR devices market share is expected to witness high growth over the forecast period of 2023 to 2030, spurred by increasing focus on public-access defibrillation programs.
Regional analysis: North America dominates the global market currently due to supportive government policies and rising healthcare expenditure. However, Asia Pacific is anticipated to grow at the fastest pace during the forecast period driven by growing medical infrastructure, rising healthcare awareness, and increasing prevalence of cardiac diseases in countries like China and India.
Key players: Key players operating in the automated CPR devices market are AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd. These players are focusing on new product launches and geographic expansion to strengthen their market positions.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
